LOTUSEYENSELotus Eye Hospital and Institute Limited· MiscellaneousMediumNeutral
Announced Mon, 22 Sept · 11:48 IST

Sangeetha Sundaramoorthy has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Promoter Stake BuyOwnership Changes View source PDF

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sangeetha Sundaramoorthy has filed a disclosure with the stock exchange under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This report relates to an acquisition of shares made by relying on the exemption provided under Regulation 10, which covers certain inter se transfers and intra-group acquisitions among promoters. The filing is a routine regulatory disclosure required when shares are acquired under such an exempt category rather than through the normal open offer route.

Likely market impact

This is a routine regulatory compliance filing and is unlikely to have a material impact on the stock price. It indicates internal restructuring or transfer of shares within the promoter/promoter group rather than a change in overall promoter control of the company.